ROSE-010

glucagon-like peptide-1 analogue · Rose Pharma Inc

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ROSE-010, covering 2013-05-31 to 2025-09-05. Get the full timeline:

Most recent: Clinical Trial Update: Effect of GLP-1 Analogue ROSE-010 on Appetite in Overweight and Obese Subjects [Phase 2]